Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Zhongguo Shi Yan Xue Ye Xue Za Zhi|July 3, 2013
[Relationship between microRNA-155 and hematological malignancies]Hua Xue, Luo-Ming Hua, Jian-Min LuoOncology Reports|September 2, 2014
SHIP1 is targeted by miR-155 in acute myeloid leukemiaHua Xue, Luo-Ming Hua, Ming Guo, et al.Oncology Reports|May 8, 2026
[Retracted] SHIP1 is targeted by miR‑155 in acute myeloid leukemiaHua Xue, Luo-Ming Hua, Ming Guo, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 17, 2018
[Research Advances of Molecular Genetic Abnormality in Myelodysplastic Syndrome--Review]Yan-Bin Pang, Ping Wu, Luo-Ming Hua, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 15, 2019
[Inhibitory Effect of Decitabine-inhibeting Methylation of SHP-1 Gene on Proliferation and Apoptosis of MDS Cell Line Skm-1]Ying Han, Jin Zhang, Jing Ji, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 9, 2018
[Mechanism and Its Countermeasure of Hypomethylating Agent Resistance in Patients with Myelodysplastic Syndrome--Review]Yan-Bin Pang, Li-Xia Fan, Hua Xue, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 17, 2018
[Lymphocyte Count before First Consolidation Therapy Is A Predictor of Relapse free Survival in Acute Myeloid Leukemia]Yan-Bin Pang, Li-Xia Fan, Ming-Jie Tian, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|December 30, 2014
[Efects of Inhibiting miR-155 Expression on the Proliferation and Apoptosis of Leukemia THP-1 Cells]Hua Xue, Lu Liang, Hui-Mei Guo, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|December 4, 2018
[Predicting Therapeutic Response by Lymphocyte Level at 28th Day after DAC Treatment in Patients with MDS]Ming-Jie Tian, Song-Ying Zhao, Hua Xue, et al.Leukemia & Lymphoma|June 9, 2021
Treatment and outcome patterns of patients with Waldenström's macroglobulinemia: a large, multicenter retrospective review in ChinaXin-Xin Cao, Shu-Hua Yi, Zhong-Xing Jiang, et al.Pageof 1